4 ms·

Yes, is the answer to your question. The article already mentions an Indian manufacturer getting up to speed with this vaccine, with 150 million doses already

Yes, is the answer to your question. The article already mentions an Indian manufacturer getting up to speed with this vaccine, with 150 million doses already manufactured. If you search for “lack of covid vaccines in Africa” there are many, many results. I’m tempted to say you’ve asked the question with a very Western mindset, not really considering less developed nations.

Arnt 5y ago
My question stands. India had vaccine manufacturing already, with over a billion doses of locally produced covid vaccines dispensed and much more than that produced. Clearly the patents and pricing weren't debilitating problems.
- phillc73 5y ago
  “India never should have been in this position. The government is currently engaged in international disputes over vaccine waivers and intellectual property rights, while a horrific and record-setting surge of COVID-19 cases continues to devastate its population. The country’s recent vaccine policies — opening vaccination for all above the age of 18 while reeling under severe shortage…” May 17th, 2021 https://www.theverge.com/2021/5/17/22440292/vaccine-waivers-india-covid-19-coronavirus https://www.theverge.com/2021/5/17/22440292/vaccine-waivers-...
  - Arnt 5y ago
    Even if India never should have been in this position, the cost of its being in this position seems manageable. By way of comparison, India spends 6-7 times as much money on its air force as on buying corona vaccines. This isn't a large budget item, not a large problem. There were shortages, but AFAICT those weren't related either to pricing or to patents. The government ordered what it thought necessary, the manufacturer set up production to match that and delivered doses as ordered. Then more was needed and scaling up further took time. Overall, I can't see reason to count the three problems in the headline as big problems for India.

Arnt 5y ago

My question stands. India had vaccine manufacturing already, with over a billion doses of locally produced covid vaccines dispensed and much more than that produced. Clearly the patents and pricing weren't debilitating problems.

phillc73 5y ago
“India never should have been in this position. The government is currently engaged in international disputes over vaccine waivers and intellectual property rights, while a horrific and record-setting surge of COVID-19 cases continues to devastate its population. The country’s recent vaccine policies — opening vaccination for all above the age of 18 while reeling under severe shortage…” May 17th, 2021 https://www.theverge.com/2021/5/17/22440292/vaccine-waivers-india-covid-19-coronavirus https://www.theverge.com/2021/5/17/22440292/vaccine-waivers-...
- Arnt 5y ago
  Even if India never should have been in this position, the cost of its being in this position seems manageable. By way of comparison, India spends 6-7 times as much money on its air force as on buying corona vaccines. This isn't a large budget item, not a large problem. There were shortages, but AFAICT those weren't related either to pricing or to patents. The government ordered what it thought necessary, the manufacturer set up production to match that and delivered doses as ordered. Then more was needed and scaling up further took time. Overall, I can't see reason to count the three problems in the headline as big problems for India.